DNA methylation and chromatin structure regulate PU. 1 Expression

DNA and Cell Biology

Volumn 18, Issue 12, 1999, Pages 875-884

  Amaravadi, Lakshmi ^a,b   Klemsz, Michael J ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ARTICLE; B LYMPHOCYTE; CELL FATE; CELL SPECIFICITY; CHROMATIN STRUCTURE; DNA METHYLATION; EXON; FIBROBLAST; GENE EXPRESSION REGULATION; GROWTH REGULATION; HEMATOPOIESIS; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033377786     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454999314737     Document Type: Article

References (36)

1. AGARWAL, S., and RAO, A. (1998). Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity 9, 765-775.
2. ANDERSON, M.K., HERNANDEZ-HOYOS, G., DIAMOND, R.A., and ROTHENBERG, E.V. (1999). Precise developmental regulation of Ets family transcription factors during specification and commitment to the T cell lineage. Development 126, 3131-3148.
3. BHATTACHARYA, S.K., RAMCHANDANI, S., CERVONI, N., and SZYF, M. (1999). A mammalian protein with specific demethylase activity for mCpG DNA. Nature 397, 579-583.
4. BIRD, A. (1992). The essentials of DNA methylation. Cell 70, 5-8.
5. BRANDEIS, M., ARIEL, M., and CEDAR, H. (1993). Dynamics of DNA methylation during development. Bioessays 15, 709-713.
6. BRUNK, B.B., GOLDHAMER, D.J., and EMERSON, C.P. (1996). Regulated demethylation of the myoD distal enhancer during skeletal myogenesis. Dev. Biol. 177, 490-503.
7. COUNTS, J.L., and GOODMAN, J.I. (1995). Alterations in DNA methylation may play a variety of roles in carcinogenesis. Cell 83, 13-15.
8. EDEN, S., and CEDAR, H. (1994). Role of DNA methylation in the regulation of transcription. Curr. Opin. Genet. Dev. 4, 255-259.
9. GROSS, D.S., and GARRARD, W.T. (1988). Nuclease hypersensitive sites in chromatin. Annu. Rev. Biochem. 57, 159-197.
10. HROMAS, R., ORAZI, A., NEIMAN, R.S., MAKI, R., VAN BEVEREN, C., MOORE, J., and KLEMSZ, M.J. (1993). Hematopoietic lineage and stage restricted expression of the ets oncogene family member, PU.1. Blood 82, 2998-3004.
11. JONES, P.A. (1999). The DNA methylation paradox. Trends Genet. 15, 34-37.
12. JOHNSON, C.A., GODDARD, J.P., and ADAMS, R.L.P. (1995). The effect of histone H1 and DNA methylation on transcription. Biochem. J. 305, 791-798.
13. KARIM, F.D., URNESS, L.D., THUMMEL, C.S., KLEMSZ, M.J., MCKERCHER, S.R., CELADA, A., VAN BEVEREN, C., MAKI, R.A., GUNTHER, C.V., NYE, J.A., and GRAVES, B.J. (1990). The ETS-domain: A new DNA binding motif that recognizes a purine-rich core DNA sequence. (letter). Genes Dev. 4, 1451-1453.
14. KLEMSZ, M.J., MCKERCHER, S.R., CELADA, A., VAN BEVEREN, C., and MAKI, R.A. (1990). The macrophage and B cell specific transcription factor PU.1 is related to the ets oncogene. Cell 61, 113-124.
15. KLEMSZ, M.J., and MAKI, R.A. (1996). Activation of transcription by PU.1 requires both acidic and glutamine domains. Mol. Cell. Biol. 16, 390-397.
16. KODANDAPANI, R., PIO, F., NI, C-Z., PICCIALLI, G., KLEMSZ, M., MCKERCHER, S.R., MAKI, R.A., and ELY, K.R. (1996). A new pattern for helix-turn-helix recognition revealed by the PU.1 ETS-domain-DNA complex. Nature 380, 456-460.
17. LI, E., BESTOR, T.H., and JAENISCH, R. (1992). Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69, 915-926.
18. LI, E., BEARD, C., and JAENISCH, R. (1993). Role for DNA methylation in genomic imprinting. Nature 366, 362-365.
19. LICHTENSTEIN, M., KEINI, G., CEDAR, H., and BERGMAN, Y. (1994). B cell-specific demethylation: A novel role for the intronic κ chain enhancer sequence. Cell 76, 913-923.
20. LIOU, H-C., POLLA, B.S., ARAGNOL, D., LESERMAN, L.D., GRIFFITH, I.J., and GLIMCHER, L.H. (1988). A tissue-specific DNase I-hypersensitive site in a class II A gene is under trans-regulatory control. Proc. Natl. Acad. Sci. USA 85, 2738-2742.
21. MCKERCHER, S.R., TORBETT, B.E., ANDERSON, K.L., HENKEL, G.W., VESTAL, D.J., BARIBAULT, H., KLEMSZ, M., FEENEY, A.J., WU, G.E., PAIGE, C.J., and MAKI, R.A. (1996). Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15, 5647-5658.
22. MOREAU-GACHELIN, F., RAY, D., MATTEI, M-G., TAMBOURIN, P., and TAVITAN, A. (1989). The putative oncogene spi-1: Murine chromosomal localization and transcriptional activation in murine acute erythroleukemias. Oncogene 4, 1449-1456.
23. MOREAU-GACHELIN, F., WENDLING, F., MOLINA, T., DENIS, N., TITEUX, M., GRIMBER, G., BRIAND, P., VAINCHENKER, W., and TAVITAN, A. (1996). Spi-1/PU.1 transgenic mice develop multistep erythroleukemias. Mol. Cell. Biol. 16, 2453-2463.
24. NELSEN, B., TIAN, G., ERMAN, B., GREGOIRE, J., MAKI, R., GRAVES, B., and SEN, R. (1993). Regulation of lymphoid-specific immunoglobulin μ heavy chain gene enhancer by ETS-domain proteins. Science 261, 82-86.
25. OLSON, M.C., SCOTT, E.W., HACK, A.A., SU, G.H., TENEN, D.G., SINGH, H., and SIMON, M.C. (1995). PU.1 is not essential for early myeloid gene expression but is required for terminal myeloid differentiation. Immunity 3, 703-714.
26. PAUL, R., SCHUETZE, S., KOZAK, S.L., KOZAK, C.A., and KABAT, D. (1991). The sfpi-1 proviral integration site of Friend erythroleukemia encodes the ets-related transcription factor PU.1. J. Virol. 65, 464-467.
27. RAMCHANDANI, S., BHATTACHARYA, S.K., CERVONI, N., and SZYF, M. (1999). DNA methylation is a reversible biological signal. Proc. Natl. Acad. Sci. USA 96, 6107-6112.
28. RAZIN, A., and CEDAR, H. (1994). DNA methylation and genomic imprinting. Cell 77, 473-476.
29. ROQUE, M.C., SMITH, P.A., and BLASQUEZ, V.C. (1996). A developmentally modulated chromatin structure at the immunoglobulin κ 3′ enhancer. Mol. Cell. Biol. 16, 3138-3155.
30. SCOTT, E.W., SIMON, M.C., ANASTASI, J., and SINGH, H. (1994). Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265, 1573-1577.
31. SCHUETZE, S., STENBERG, P.E., and KABAT, D. (1993). The ets-related transcription factor PU.1 immortalizes erythroblasts. Mol. Cell. Biol. 13, 5670-5678.
32. SIEGFRIED, Z., EDEN, S., MENDELSOHN, M., FENG, X., TSUBERI, B-Z., and CEDAR, H. (1999). DNA methylation represses transcription in vivo. Nature Genet. 22, 203-206.
33. SINGAL, R., and GINDER, G.D. (1999). DNA methylation. Blood 93, 4059-4070.
34. SPAIN, L.M., GUERRIERO, A., KUNJIBETTU, S., and SCOTT, E.W. (1999). T cell development in PU.1-deficient mice. J. Immunol. 163, 2681-2687.
35. SPOLSKI, R., MIESCHER, G., ERARD, F., RISSER, R., MACDONALD, H.R., and MAK, T.W. (1988). Regulation of expression of T cell gamma chain, L3T4 and Ly-2 messages in Abelson/Moloney virus-transformed T cell lines. Eur. J. Immunol. 18, 295-300.
36. VOSO, M.T., BURN, T.C., WULF, G., LIM, B., LEONE, G., and TENEN, D.G. (1994). Inhibition of hematopoiesis by competitive binding of transcription factor PU.1. Proc. Natl. Acad. Sci. USA 91, 7932-7936.